Overexpression of CRKL correlates with malignant cell proliferation in breast cancer

Derlin-1 Is Overexpressed in Non-Small Cell Lung Cancer and Promotes Cancer Cell Invasion via EGFR-ERK–Mediated Up-Regulation of MMP-2 and MMP-9

(2013) Qian-ze Dong et al.   AMERICAN JOURNAL OF PATHOLOGY

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer

(2012) Mohamed Elfagieh et al.   TUMOR BIOLOGY

Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an immunohistochemical and proteomics-based strategy

(2012) Maria Kabbage et al.   TUMOR BIOLOGY

CRKL as a Lung Cancer Oncogene and Mediator of Acquired Resistance to EGFR Inhibitors: Is It All That It Is Cracked Up to Be?

(2011) M. Ladanyi   Cancer Discovery

Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy

(2010) Yan Shi et al.   TUMOR BIOLOGY

Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition

(2009) O. K. Mirzoeva et al.   CANCER RESEARCH

Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer

(2009) Y H Kim et al.   ONCOGENE

An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment

(2009) P. J. Mintz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA